Kollmar, R: Therapeutic Hypothermia - Principles, Indication
en Hardback – dec 2012
Preț: 264.05 lei
Nou
Puncte Express: 396
Preț estimativ în valută:
50.53€ • 52.49$ • 41.98£
50.53€ • 52.49$ • 41.98£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783837413717
ISBN-10: 3837413713
Pagini: 96
Ilustrații: 18 illustrations
Dimensiuni: 174 x 246 x 12 mm
Greutate: 0.33 kg
Editura: Uni-Med Verlag Ag
ISBN-10: 3837413713
Pagini: 96
Ilustrații: 18 illustrations
Dimensiuni: 174 x 246 x 12 mm
Greutate: 0.33 kg
Editura: Uni-Med Verlag Ag
Cuprins
1. Definitions and Standardization of Terminology in Nocturia 142. Prevalence and Bother of Nocturia 182.1. Forewords of definition 182.2. Prevalence 192.3. Questionnaire versus frequency-volume chart in assessment of nocturia prevalence 202.4. Bother of nocturia 212.5. Conclusions 233. Pathophysiology of Nocturia 283.1. Urinary tract pathophysiology of nocturia 283.1.1. Renal causes of nocturia 283.1.2. Overactive bladder 293.1.3. Benign prostate enlargement 303.1.4. Neurogenic bladder 313.1.5. Bladder pain syndrome 313.1.6. Differential diagnosis 323.1.7. Conclusions 323.2. Nocturia and heart diseases 353.2.1. Pathophysiology of nocturia in heart failure 353.2.2. Management of heart failure 413.2.3. Summary 433.3. Nocturia and pulmonary diseases 453.3.1. Association of nocturia and pulmonary disease 453.3.2. Pulmonary hypertension 453.3.3. Pulmonary mechanisms causing nocturia 453.3.4. Pulmonary diseases associated with nocturia 463.3.5. Summary 524. Impact of Nocturia on Sleep and Quality of Life 564.1. Impact of nocturia on Quality of Sleep 564.1.1. Normal sleep 564.1.2. Sleep, how much is enough? 564.1.3. Sleep and age 574.1.4. Insights into the consequences of sleep disturbance: proof from nocturia 584.1.5. Conclusions 604.2. Nocturia and impact on Quality of Life 624.2.1. Definition of Health-Related Quality of Life (HRQoL) 624.2.2. HRQoL - The need for a reliable and valid instrument 624.2.3. Disease-specific vs. generic questionnaires 634.2.4. Is QoL worth assessing? 634.2.5. QoL and nocturia 644.2.6. Conclusion 685. Assessment of Nocturia and Nocturnal Polyuria 725.1. Nocturnal polyuria 735.2. Decreased nocturnal bladder capacity 745.3. Mixed nocturia 755.4. Global polyuria 756. Management of Nocturia and Treatment Algorithms 806.1. Behavioural strategies 806.2. Therapy for concomitant (non-urological) disorders 816.3. Treatment of sleep disorders 816.4. Pharmacological therapy for urological disorders 816.4.1. Targeting the bladder or prostate 816.4.2. Targeting the kidney - antidiuretic therapy 826.4.3. Gender differences during desmopressin treatment 856.4.4. Combination therapy 856.5. Prostate surgery 866.6. Patient-related benefits of nocturia therapy 866.7. Conclusions 877. Outlook - Future Developments in the Treatment of Nocturia 927.1. The impact of definitions 927.2. How do we measure nocturia and its impact? 927.3. One symptom - many causes 937.4. What are meaningful treatment goals? 937.5. Future treatments 94Index 95